Bio-Techne (TECH) Net Margin Growth (3y) (2012 - 2026)

Bio-Techne (TECH) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -374.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -44.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -759,845.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 7,793.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 82,312.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -5,319.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 9,934.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 31,387.00
10 Bio-Techne 11.33 Bn 11.12 Bn 208.29 Mn -748.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -748.00
Dec 31, 2025 -557.00
Sep 30, 2025 -447,337.00
Jun 30, 2025 -5,690.00
Mar 31, 2025 -1,357.00
Dec 31, 2024 -1,501.00
Sep 30, 2024 -1,516.00
Jun 30, 2024 175.00
Mar 31, 2024 -247.00
Dec 31, 2023 -1,050.00
Sep 30, 2023 206.00
Jun 30, 2023 154.00
Mar 31, 2023 516.00
Dec 31, 2022 -4,627.00
Sep 30, 2022 447,884.00
Jun 30, 2022 5,609.00
Mar 31, 2022 -344.00
Dec 31, 2021 1,670.00
Sep 30, 2021 1,609.00
Jun 30, 2021 -283.00